School of Biomedical Sciences is pleased to invite you to join the following seminar:

Date: 30 May 2023 (Tuesday)
Time: 3:00 pm – 4:00 pm
Venue: Lecture Theatre 1, G/F, William M.W. Mong Block, 21 Sassoon Road

Speaker: Dr. Angela Ruohao Wu, Associate Professor, Division of Life Science; Department of Chemical and Biological Engineering, Hong Kong University of Science and Technology
Talk Title: Genomics and microfluidics technology for life sciences research

Biography

Angela Wu is an Associate Professor in the Division of Life Science and the Department of Chemical and Biological Engineering at Hong Kong University of Science and Technology (HKUST). Angela is passionate about the development of new technologies at the interface of basic biology and engineering, and her research group is using these interdisciplinary approaches to investigate biological mechanisms and human diseases. Early in her scientific career, she was named a Siebel Scholar in 2010, and was also awarded a Bio-X Bowes Fellowship for her research. In 2015, Angela also co-founded Agenovir Corporation, a CRISPR-based therapeutics company targeting infectious diseases for a complete cure. While at Agenovir, she helped to successfully raise Series A venture capital funding of US$10.6M. Agenovir was recently acquired. As recognition of her achievements in technology and innovation, Dr. Wu was named one of MIT Technology Review Innovators under 35 Asia in 2016, and a World Economic Forum Young Scientist in 2018.

Abstract
Recent advancements in engineering technologies have spurred a movement toward more quantitative approaches to biology. The ability to make quantitative measurements of biological systems has enabled a higher resolution and more nuanced view at every level, from organismal level organization down to cellular level molecular processes. High-throughput DNA sequencing and the rapidly evolving field of genomics are prominent examples of how such technologies can revolutionize biology and medicine. In this seminar, I will talk about how we use technologies such as single-cell genomics and microfluidics to empower life science research. In particular, I will talk about our latest single-cell multi-omic method called scONE-seq, which has allowed us to dissect the complex heterogeneity of a glioma tumor and identify a rare clone with a potential role in regulating tumor microenvironment.
 

ALL ARE WELCOME

Should you have any enquiries, please feel free to contact Miss Angela Wong at 3917 9216.